Your session is about to expire
← Back to Search
ComBaT for Glaucoma
N/A
Waitlist Available
Led By Angela Elam
Research Sponsored by University of Michigan
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 14 months
Awards & highlights
No Placebo-Only Group
Summary
This trial looks into if more resources can help people get eye care to prevent blindness and glaucoma.
Who is the study for?
This trial is specifically for Black or African American individuals who have already taken part in the screening exam phase of the study. It aims to see if extra support and education can encourage them to regularly visit eye care professionals, potentially preventing blindness due to glaucoma.
What is being tested?
The ComBaT Glaucoma intervention is being tested to determine whether providing additional resources and education can improve a person's likelihood of seeking regular eye care services, which could help prevent vision loss from glaucoma.
What are the potential side effects?
Since this trial focuses on behavioral intervention through education rather than medication, there are no direct medical side effects. However, participants may experience changes in their healthcare routines.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 14 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 14 months
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Eye care utilization
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: Eye concernExperimental Treatment1 Intervention
Those with a diagnosis of glaucoma or glaucoma suspect (or other concerning eye disease, such as diabetic retinopathy or macular degeneration) will be invited to participate in the ComBaT Glaucoma.
Find a Location
Who is running the clinical trial?
National Institute on Minority Health and Health Disparities (NIMHD)NIH
439 Previous Clinical Trials
1,412,282 Total Patients Enrolled
University of MichiganLead Sponsor
1,860 Previous Clinical Trials
6,440,942 Total Patients Enrolled
7 Trials studying Glaucoma
1,442 Patients Enrolled for Glaucoma
Angela ElamPrincipal InvestigatorUniversity of Michigan